SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. E. McCarthy, M. O'Brien, J. Andrews, J. M. Zoland, E. Macasiray, W. Wong, C. Lo, B. Glader, J. Tamaresis, M. Jeng, Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator, Haemophilia, 2016, 22, 1
  2. 2
    K. Vepsäläinen, R. Lassila, M. Arola, P. Lähteenmäki, M. Möttönen, A. Mäkipernaa, P. Riikonen, Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland, Haemophilia, 2015, 21, 6
  3. 3
    Chris Barnes, Recent Advances in Haemophilia Management, Current Pediatrics Reports, 2015, 3, 2, 154

    CrossRef

  4. 4
    Paola Giordano, Giuseppe Lassandro, Michele Valente, Angelo Claudio Molinari, Paola Ieranò, Antonio Coppola, Current Management of the Hemophilic Child: A Demanding Interlocutor. Quality of Life and Adequate Cost-Efficacy Analysis, Pediatric Hematology and Oncology, 2014, 31, 8, 687

    CrossRef